品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 |
R022011-1g 当天发货 |
1g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97% |
|
|
罗恩 |
R022011-5g 当天发货 |
5g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97% |
|
|
阿拉丁 | M122235-250mg | 250mg | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97% |
|
|
阿拉丁 | M122235-1g | 1g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97% |
|
|
阿拉丁 | M122235-5g | 5g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97% |
|
|
阿拉丁 | M122235-25g | 25g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97% |
|
|
阿拉丁 | M122235-100g | 100g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97% |
|
|
阿拉丁 | M425780-1ml | 1ml | 期货,请咨询 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
10mM in DMSO |
|
|
韶远 | SY021699-25g | 25g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
≥97% |
|
|
韶远 | SY021699-1g | 1g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
≥97% |
|
|
韶远 | SY021699-5g | 5g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
≥97% |
|
|
韶远 | SY021699-10g | 10g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
≥97% |
|
|
韶远 | SY021699-100g | 100g | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
≥97% |
|
|
梯希爱 | M1962-200MG | 200MG | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97.0%GC |
|
|
梯希爱 | M1962-1G | 1G | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97.0%GC |
|
|
梯希爱 | M1962-5G | 5G | 现货 | 7423-55-4 |
3-马来酰亚胺基丙酸 3-Maleimidopropionic Acid |
97.0%GC |
|
|
毕得 | BD34019-1g | 1g | 现货 | 7423-55-4 |
3-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)... 3-(2,5-Dioxo-2,5-dihydro-1H-... |
95% |
|
|
毕得 | BD34019-5g | 5g | 现货 | 7423-55-4 |
3-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)... 3-(2,5-Dioxo-2,5-dihydro-1H-... |
95% |
|
|
毕得 | BD34019-10g | 10g | 现货 | 7423-55-4 |
3-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)... 3-(2,5-Dioxo-2,5-dihydro-1H-... |
95% |
|
|
毕得 | BD34019-25g | 25g | 现货 | 7423-55-4 |
3-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)... 3-(2,5-Dioxo-2,5-dihydro-1H-... |
95% |
|
|